Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 65,170 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.28% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 92,204 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 0.69% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 12,691 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 3.6% of the total position.
ARKG Investment Tracker position change: Decreased position in Personalis by 58,408 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 5.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 15,393 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.37% of the total position.
ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 89,236 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 5.01% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 20,720 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 8.35% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,061 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.8% of the total position.
ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 8,302 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 10,731 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.04% of the total position.
ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 41,377 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.29% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 4,340 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.17% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 26,472 shares, the number of shares held decreased 0.99% compared to the previous period and now represents 1.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 18,935 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.24% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 7,420 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.88% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 19,992 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 3.43% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 14,588 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.39% of the total position.
ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 38,717 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 3.23% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 92,204 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 0.69% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 65,170 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.28% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 15,393 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.37% of the total position.
$ServiceNow(NOW)$ I'm continuing to DCA into ServiceNow ($NOW) because I still believe the long-term fundamentals remain much stronger than the short-term price action suggests. ServiceNow is no longer simply an IT workflow company—it is positioning itself as an AI control tower for enterprises, connecting AI, data, security and workflows on a single platform. Its Q2 2026 results reinforced that thesis, with subscription revenue growing 24.5% year over year and remaining performance obligations reaching $29 billion. What gives me confidence is that the AI story is increasingly translating into real commercial adoption. ServiceNow AI crossed $1 billion in annual contract value in Q2, while agentic AI deployments increased significantly. The com
ARKG Investment Tracker position change: Decreased position in Personalis by 58,408 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 5.96% of the total position.
ARKX Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 748 shares, the number of shares held decreased 2.25% compared to the previous period and now represents 1.99% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 12,691 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 3.6% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 118,300 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.39% of the total position.
ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 89,236 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 5.01% of the total position.
ARKX Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 22,462 shares, the number of shares held decreased 2.27% compared to the previous period and now represents 8% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 20,720 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 8.35% of the total position.
$Direxion Daily Semiconductors Bull 3x Shares(SOXL)$ I'm continuing to add to my SOXL position during this semiconductor pullback. I'm not trying to catch the exact bottom—I'm positioning for what I believe could be a near-term rebound. Technically, the pullback toward the 200-day EMA is important to me. This long-term trendline has historically acted as a key support area, and if buyers step in around here, the current weakness could turn into another higher-low rather than a deeper breakdown. Fundamentally, I still believe the semiconductor story remains strong. AI infrastructure, data centers, high-performance computing and memory demand continue to provide structural support for the sector. A correction doesn't necessarily change that lon
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,061 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.8% of the total position.
ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 41,377 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.29% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 19,992 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 3.43% of the total position.
ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 10,731 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 1.04% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 26,472 shares, the number of shares held decreased 0.99% compared to the previous period and now represents 1.74% of the total position.
ARKK Investment Tracker position change: Increased position in BWX Technologies Inc by 33,044 shares, the number of shares held increased 11.57% compared to the previous period and now represents 0.82% of the total position.